Skip to main content
Erschienen in: European Radiology 4/2013

01.04.2013 | Hepatobiliary-Pancreas

MR findings of steatotic focal nodular hyperplasia and comparison with other fatty tumours

verfasst von: Maxime Ronot, Valérie Paradis, Rafael Duran, Anne Kerbaol, Marie-Pierre Vullierme, Jacques Belghiti, Dominique-Charles Valla, Valérie Vilgrain

Erschienen in: European Radiology | Ausgabe 4/2013

Einloggen, um Zugang zu erhalten

Abstract

Objectives

To correlate MR findings with pathology in steatotic FNHs and to compare the MR findings with those of other fatty tumours developed on noncirrhotic liver in a consecutive series of resected lesions.

Methods

Our population included resected FNH with intralesional steatosis (n = 25) and other resected fatty tumours selected as controls (hepatocellular adenomas and angiomyolipomas, n = 34). Lesions were classified into three groups: those with typical FNH without (group 1) or with (group 2) fat on MR and those with atypical lesions (group 3). In group 3, diagnostic criteria for other fatty tumours were applied.

Results

There were 9 lesions in group 1 (15.3 %), 4 in group 2 (16.8 %) and 46 in group 3 (77.9 %). Group 3 contained 12 FNHs (26 %) and all the other fatty tumours. In group 3, the association of lesion homogeneity, signal intensity similar to or slightly different from adjacent liver on in-phase T1- and T2-weighted sequences, and strong arterial enhancement was observed in 7/12 (58 %) of steatotic FNHs and 3/34 (9 %) of other tumours.

Conclusion

On MR, fat within a typical FNH should not reduce the diagnostic confidence. We recommend further investigations including liver biopsy if necessary when fatty tumours exhibit atypical MR findings.

Key Points

MRI is increasingly used to assess hepatic lesions containing fat.
Nodules of focal nodular hyperplasia often contain foci of fat.
However, steatotic FNH does not always demonstrate typical fatty features on MRI.
The main mimickers of steatotic FNHs are telangiectatic/inflammatory hepatocellular adenomas.
We recommend liver biopsy when fatty tumours exhibit atypical MR findings.
Literatur
1.
Zurück zum Zitat Paradis V, Benzekri A, Dargère D et al (2004) Telangiectatic focal nodular hyperplasia: a variant of hepatocellular adenoma. Gastroenterology 126:1323–1329PubMedCrossRef Paradis V, Benzekri A, Dargère D et al (2004) Telangiectatic focal nodular hyperplasia: a variant of hepatocellular adenoma. Gastroenterology 126:1323–1329PubMedCrossRef
2.
Zurück zum Zitat Gaffey MJ, Iezzoni JC, Weiss LM (1996) Clonal analysis of focal nodular hyperplasia of the liver. Am J Pathol 148:1089–1096PubMed Gaffey MJ, Iezzoni JC, Weiss LM (1996) Clonal analysis of focal nodular hyperplasia of the liver. Am J Pathol 148:1089–1096PubMed
3.
Zurück zum Zitat Rebouissou S, Bioulac-Sage P, Zucman-Rossi J (2008) Molecular pathogenesis of focal nodular hyperplasia and hepatocellular adenoma. J Hepatol 48:163–170PubMedCrossRef Rebouissou S, Bioulac-Sage P, Zucman-Rossi J (2008) Molecular pathogenesis of focal nodular hyperplasia and hepatocellular adenoma. J Hepatol 48:163–170PubMedCrossRef
4.
Zurück zum Zitat Dokmak S, Paradis V, Vilgrain V et al (2009) A single-center surgical experience of 122 patients with single and multiple hepatocellular adenomas. Gastroenterology 137:1698–1705PubMedCrossRef Dokmak S, Paradis V, Vilgrain V et al (2009) A single-center surgical experience of 122 patients with single and multiple hepatocellular adenomas. Gastroenterology 137:1698–1705PubMedCrossRef
5.
Zurück zum Zitat Farges O, Ferreira N, Dokmak S et al (2011) Changing trends in malignant transformation of hepatocellular adenoma. Gut 60:85–89PubMedCrossRef Farges O, Ferreira N, Dokmak S et al (2011) Changing trends in malignant transformation of hepatocellular adenoma. Gut 60:85–89PubMedCrossRef
6.
Zurück zum Zitat Weimann A, Ringe B, Klempnauer J et al (1997) Benign liver tumours: differential diagnosis and indications for surgery. World J Surg 21:983–990PubMedCrossRef Weimann A, Ringe B, Klempnauer J et al (1997) Benign liver tumours: differential diagnosis and indications for surgery. World J Surg 21:983–990PubMedCrossRef
8.
Zurück zum Zitat Bioulac-Sage P, Balabaud C, Bedossa P et al (2007) Pathological diagnosis of liver cell adenoma and focal nodular hyperplasia: Bordeaux update. J Hepatol 46:521–527PubMedCrossRef Bioulac-Sage P, Balabaud C, Bedossa P et al (2007) Pathological diagnosis of liver cell adenoma and focal nodular hyperplasia: Bordeaux update. J Hepatol 46:521–527PubMedCrossRef
9.
Zurück zum Zitat Prasad SR, Wang H, Rosas H et al (2005) Fat-containing lesions of the liver: radiologic–pathologic correlation. RadioGraphics 25:321–331PubMedCrossRef Prasad SR, Wang H, Rosas H et al (2005) Fat-containing lesions of the liver: radiologic–pathologic correlation. RadioGraphics 25:321–331PubMedCrossRef
10.
Zurück zum Zitat Basaran C, Karcaaltincaba M, Akata D et al (2005) Fat-containing lesions of the liver: cross-sectional imaging findings with emphasis on MRI. AJR Am J Roentgenol 184:1103–1110PubMedCrossRef Basaran C, Karcaaltincaba M, Akata D et al (2005) Fat-containing lesions of the liver: cross-sectional imaging findings with emphasis on MRI. AJR Am J Roentgenol 184:1103–1110PubMedCrossRef
11.
Zurück zum Zitat Valls C, Iannacconne R, Alba E et al (2006) Fat in the liver: diagnosis and characterization. Eur Radiol 16:2292–2308PubMedCrossRef Valls C, Iannacconne R, Alba E et al (2006) Fat in the liver: diagnosis and characterization. Eur Radiol 16:2292–2308PubMedCrossRef
12.
Zurück zum Zitat Bioulac-Sage P, Rebouissou S, Thomas C et al (2007) Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry. Hepatology 46:740–748PubMedCrossRef Bioulac-Sage P, Rebouissou S, Thomas C et al (2007) Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry. Hepatology 46:740–748PubMedCrossRef
13.
Zurück zum Zitat Zucman-Rossi J, Jeannot E, Nhieu JT et al (2006) Genotype–phenotype correlation in hepatocellular adenoma: new classification and relationship with HCC. Hepatology 43:515–524PubMedCrossRef Zucman-Rossi J, Jeannot E, Nhieu JT et al (2006) Genotype–phenotype correlation in hepatocellular adenoma: new classification and relationship with HCC. Hepatology 43:515–524PubMedCrossRef
14.
Zurück zum Zitat van Aalten SM, Thomeer MG, Terkivatan T et al (2011) Hepatocellular adenomas: correlation of MR imaging findings with pathologic subtype classification. Radiology 261:172–181PubMedCrossRef van Aalten SM, Thomeer MG, Terkivatan T et al (2011) Hepatocellular adenomas: correlation of MR imaging findings with pathologic subtype classification. Radiology 261:172–181PubMedCrossRef
15.
Zurück zum Zitat Ronot M, Bahrami S, Calderaro J et al (2011) Hepatocellular adenomas: accuracy of magnetic resonance imaging and liver biopsy in subtype classification. Hepatology 53:1182–1191PubMedCrossRef Ronot M, Bahrami S, Calderaro J et al (2011) Hepatocellular adenomas: accuracy of magnetic resonance imaging and liver biopsy in subtype classification. Hepatology 53:1182–1191PubMedCrossRef
16.
Zurück zum Zitat Laumonier H, Bioulac-Sage P, Laurent C et al (2008) Hepatocellular adenomas: magnetic resonance imaging features as a function of molecular pathological classification. Hepatology 48:808–818PubMedCrossRef Laumonier H, Bioulac-Sage P, Laurent C et al (2008) Hepatocellular adenomas: magnetic resonance imaging features as a function of molecular pathological classification. Hepatology 48:808–818PubMedCrossRef
17.
Zurück zum Zitat Högemann D, Flemming P, Kreipe H, Galanski M (2001) Correlation of MRI and CT findings with histopathology in hepatic angiomyolipoma. Eur Radiol 11:1389–1395PubMedCrossRef Högemann D, Flemming P, Kreipe H, Galanski M (2001) Correlation of MRI and CT findings with histopathology in hepatic angiomyolipoma. Eur Radiol 11:1389–1395PubMedCrossRef
18.
Zurück zum Zitat Horton KM, Bluemke DA, Hruban RH, Soyer P, Fishman EK (1999) CT and MR imaging of benign hepatic and biliary tumours. RadioGraphics 19:431–451PubMed Horton KM, Bluemke DA, Hruban RH, Soyer P, Fishman EK (1999) CT and MR imaging of benign hepatic and biliary tumours. RadioGraphics 19:431–451PubMed
19.
Zurück zum Zitat Bioulac-Sage P, Laumonier H, Rullier A et al (2009) Over-expression of glutamine synthetase in focal nodular hyperplasia: a novel easy diagnostic tool in surgical pathology. Liver Int 29:459–465PubMedCrossRef Bioulac-Sage P, Laumonier H, Rullier A et al (2009) Over-expression of glutamine synthetase in focal nodular hyperplasia: a novel easy diagnostic tool in surgical pathology. Liver Int 29:459–465PubMedCrossRef
20.
Zurück zum Zitat Bioulac-Sage P, Cubel G, Balabaud C et al (2011) Revisiting the pathology of resected benign hepatocellular nodules using new immunohistochemical markers. Semin Liver Dis 31:91–103PubMedCrossRef Bioulac-Sage P, Cubel G, Balabaud C et al (2011) Revisiting the pathology of resected benign hepatocellular nodules using new immunohistochemical markers. Semin Liver Dis 31:91–103PubMedCrossRef
21.
Zurück zum Zitat Makhlouf HR, Abdul-Al HM, Goodman ZD (2005) Diagnosis of focal nodular hyperplasia of the liver by needle biopsy. Hum Pathol 36:1210–1216PubMedCrossRef Makhlouf HR, Abdul-Al HM, Goodman ZD (2005) Diagnosis of focal nodular hyperplasia of the liver by needle biopsy. Hum Pathol 36:1210–1216PubMedCrossRef
22.
Zurück zum Zitat Ferlicot S, Kobeiter H, Tran Van Nhieu J et al (2004) MRI of atypical focal nodular hyperplasia of the liver: radiology–pathology correlation. AJR Am J Roentgenol 182:1227–1231PubMedCrossRef Ferlicot S, Kobeiter H, Tran Van Nhieu J et al (2004) MRI of atypical focal nodular hyperplasia of the liver: radiology–pathology correlation. AJR Am J Roentgenol 182:1227–1231PubMedCrossRef
23.
Zurück zum Zitat Chaoui A, Mergo PJ, Lauwers GY (1998) Unusual appearance of focal nodular hyperplasia with fatty change. AJR Am J Roentgenol 171:1433–1434PubMedCrossRef Chaoui A, Mergo PJ, Lauwers GY (1998) Unusual appearance of focal nodular hyperplasia with fatty change. AJR Am J Roentgenol 171:1433–1434PubMedCrossRef
24.
Zurück zum Zitat Mathieu D, Paret M, Mahfouz AE et al (1997) Hyperintense benign liver lesions on spin-echo TI weighted MR images: pathologic correlations. Abdom Imaging 410–417 Mathieu D, Paret M, Mahfouz AE et al (1997) Hyperintense benign liver lesions on spin-echo TI weighted MR images: pathologic correlations. Abdom Imaging 410–417
25.
Zurück zum Zitat Mitchell DG, Palazzo J, Hann HW, Rifkin MD et al (1991) Hepatocellular tumours with high signal on T1-weighted MR images: chemical shift MR imaging and histologic correlation. J Comput Assist Tomogr 15:762–769PubMedCrossRef Mitchell DG, Palazzo J, Hann HW, Rifkin MD et al (1991) Hepatocellular tumours with high signal on T1-weighted MR images: chemical shift MR imaging and histologic correlation. J Comput Assist Tomogr 15:762–769PubMedCrossRef
26.
Zurück zum Zitat Eisenberg LB, Warshauer DM, Woosley JT et al (1995) CT and MRI of hepatic focal nodular hyperplasia with peripheral steatosis. J Comput Assist Tomogr 19:498–500PubMedCrossRef Eisenberg LB, Warshauer DM, Woosley JT et al (1995) CT and MRI of hepatic focal nodular hyperplasia with peripheral steatosis. J Comput Assist Tomogr 19:498–500PubMedCrossRef
27.
Zurück zum Zitat Hussain SM, Terkivatan T, Zondervan PE et al (2004) Focal nodular hyperplasia: findings at state-of-the-art MR imaging, US, CT, and pathologic analysis. RadioGraphics 24:3–17PubMedCrossRef Hussain SM, Terkivatan T, Zondervan PE et al (2004) Focal nodular hyperplasia: findings at state-of-the-art MR imaging, US, CT, and pathologic analysis. RadioGraphics 24:3–17PubMedCrossRef
28.
Zurück zum Zitat Grazioli L, Morana G, Kirchin MA et al (2005) Accurate differentiation of focal nodular hyperplasia from hepatic adenoma at gadobenate dimeglumine-enhanced MR imaging: prospective study. Radiology 236:166–177PubMedCrossRef Grazioli L, Morana G, Kirchin MA et al (2005) Accurate differentiation of focal nodular hyperplasia from hepatic adenoma at gadobenate dimeglumine-enhanced MR imaging: prospective study. Radiology 236:166–177PubMedCrossRef
29.
Zurück zum Zitat Grazioli L, Bondioni MP, Haradome H et al (2012) Hepatocellular adenoma and focal nodular hyperplasia: value of gadoxetic acid-enhanced MR imaging in differential diagnosis. Radiology 262:520–529PubMedCrossRef Grazioli L, Bondioni MP, Haradome H et al (2012) Hepatocellular adenoma and focal nodular hyperplasia: value of gadoxetic acid-enhanced MR imaging in differential diagnosis. Radiology 262:520–529PubMedCrossRef
30.
Zurück zum Zitat Stanley G, Jeffrey RB Jr, Feliz B (2002) CT findings and mistopathology of intratumoural steatosis in focal nodular hyperplasia: case report and review of the literature. J Comput Assist Tomogr 26:815–817PubMedCrossRef Stanley G, Jeffrey RB Jr, Feliz B (2002) CT findings and mistopathology of intratumoural steatosis in focal nodular hyperplasia: case report and review of the literature. J Comput Assist Tomogr 26:815–817PubMedCrossRef
31.
Zurück zum Zitat Paradis V, Champault A, Ronot M et al (2007) Telangiectatic adenoma: an entity associated with increased body mass index and inflammation. Hepatology 46140–46146 Paradis V, Champault A, Ronot M et al (2007) Telangiectatic adenoma: an entity associated with increased body mass index and inflammation. Hepatology 46140–46146
Metadaten
Titel
MR findings of steatotic focal nodular hyperplasia and comparison with other fatty tumours
verfasst von
Maxime Ronot
Valérie Paradis
Rafael Duran
Anne Kerbaol
Marie-Pierre Vullierme
Jacques Belghiti
Dominique-Charles Valla
Valérie Vilgrain
Publikationsdatum
01.04.2013
Verlag
Springer-Verlag
Erschienen in
European Radiology / Ausgabe 4/2013
Print ISSN: 0938-7994
Elektronische ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-012-2676-y

Weitere Artikel der Ausgabe 4/2013

European Radiology 4/2013 Zur Ausgabe

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

S3-Leitlinie zu Pankreaskrebs aktualisiert

23.04.2024 Pankreaskarzinom Nachrichten

Die Empfehlungen zur Therapie des Pankreaskarzinoms wurden um zwei Off-Label-Anwendungen erweitert. Und auch im Bereich der Früherkennung gibt es Aktualisierungen.

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

18.04.2024 Pädiatrische Notfallmedizin Nachrichten

Im Choosing-Wisely-Programm, das für die deutsche Initiative „Klug entscheiden“ Pate gestanden hat, sind erstmals Empfehlungen zum Umgang mit Notfällen von Kindern erschienen. Fünf Dinge gilt es demnach zu vermeiden.

„Nur wer sich gut aufgehoben fühlt, kann auch für Patientensicherheit sorgen“

13.04.2024 Klinik aktuell Kongressbericht

Die Teilnehmer eines Forums beim DGIM-Kongress waren sich einig: Fehler in der Medizin sind häufig in ungeeigneten Prozessen und mangelnder Kommunikation begründet. Gespräche mit Patienten und im Team können helfen.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.